8-K - Prelude Therapeutics Incorporated | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. The Company has prepared investor presentation materials with information about the Company, which it intends to use as part of invest

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Presentation 104 Cover Page Interactive Data File (embedded within the Inline XB

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1